Clinical Trials
123 trialsdOCT-pBCC
Vejle Hospital
CHRU-WCMC
University Hospital, Lille
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
National Institutes of Health Clinical Center (CC)
retroESGO ov1
European Society of Gynaecological Oncology
HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
University of Calgary
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
EXOMIC
City of Hope Medical Center
Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America
Latin American Cooperative Oncology Group
FIL_MOGA
Fondazione Italiana Linfomi - ETS
Five-year Recurrence After LCME
Gødstrup Hospital
HL-R2-B2
University Hospital, Bordeaux
Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant
Astellas Pharma Inc
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation
AstraZeneca
EXCYTE-2
Exscientia AI Limited
A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Novartis
A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
Bristol-Myers Squibb
Microbiome and Colorectal Cancer Recurrence
Hospital del Mar
Circulating miRNAs.
Cancer Trials Ireland
CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL
National Institutes of Health Clinical Center (CC)
A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation
Astellas Pharma Inc
OncO2
Parc de Salut Mar
Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals
Pomalyst PMS
Celgene
Interobserver Variability Desmoplasia
Maastricht University Medical Center
RevlimidPMS
Celgene
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
Celgene
CRYO-BO-2021
IRCCS Azienda Ospedaliero-Universitaria di Bologna
The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Charles University, Czech Republic
Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling
Immatics US, Inc.
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
Pfizer
Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
Duke University
Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence
IRCCS Azienda Ospedaliero-Universitaria di Bologna
TRAIN-AI
European Hepatocellular Cancer Liver Transplant Group
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Bristol-Myers Squibb
A Study to Learn More About Copanlisib Treatment Patterns in People With Indolent Non-Hodgkin Lymphoma, a Type of Cancer That Grows and Spread Slowly and Develops in the Lymphatic System (a Part of Immune System) in Taiwan Under Real-word Conditions
Bayer
Radical Versus Conservative Surgery in Liver Cystic Echinococcosis: a Prospective Cohort Study in a High-volume Western Centre
Hospital Universitari de Bellvitge
ITIRR
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
St. Jude Children's Research Hospital
VINCat_PDO_2
Hospital de Granollers
HCC
Anhui Medical University
Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk
Fujian Medical University
Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience
Zagazig University
VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy
Tongji Hospital
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma
Celgene
Recurrence After Whipple's (RAW) Study
University Hospital Plymouth NHS Trust
VENCLL regPMOS
AbbVie
ORCHID
Regeneron Pharmaceuticals
MEDICI
AbbVie
SORI
Severance Hospital